Celgene Corp. buy marge
Start price
23.07.15
/
50%
€120.25
Target price
18.07.16
€130.79
Performance (%)
-22.85%
End price
18.07.16
€92.77
Summary
This prediction ended on 18.07.16 with a price of €92.77. The price of Celgene Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.85%. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Celgene Corp. | - | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% | 25.039% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% | 48.139% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% | 11.979% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% | 46.982% |
Comments by marge for this prediction
In the thread Celgene Corp. diskutieren
Celgene Corp.
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)